2,071 Shares in Agilent Technologies, Inc. $A Bought by Patton Fund Management Inc.

Key Points

• Patton Fund Management Inc. acquired 2,071 shares of Agilent Technologies, valued at approximately $244,000, marking a new investment in the medical research company.
• Agilent Technologies reported a quarterly EPS of $1.37, matching analysts' expectations, with revenues up 10.1% year-over-year at $1.74 billion.
• The company declared a quarterly dividend of $0.248, representing an annualized yield of 0.8%, to be paid on October 22nd.

Patton Fund Management Inc. bought a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,071 shares of the medical research company's stock, valued at approximately $244,000.

Other hedge funds also recently made changes to their positions in the company. Whipplewood Advisors LLC increased its stake in shares of Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after buying an additional 186 shares during the period. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the first quarter worth $30,000. Opal Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the first quarter worth $31,000. Ransom Advisory Ltd bought a new stake in Agilent Technologies in the first quarter valued at $32,000. Finally, Central Pacific Bank Trust Division bought a new stake in Agilent Technologies in the second quarter valued at $33,000.

Agilent Technologies Price Performance

A opened at $123.45 on Friday. The stock has a 50-day moving average price of $121.15 and a 200-day moving average price of $115.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm has a market cap of $35.00 billion, a PE ratio of 28.98, a P/E/G ratio of 4.03 and a beta of 1.24. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.Agilent Technologies's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's payout ratio is currently 23.24%.

Analysts Set New Price Targets

Several research firms recently weighed in on A. Wall Street Zen cut shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Robert W. Baird lifted their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday, August 28th. Evercore ISI cut their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a report on Thursday, August 28th. Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a report on Monday, September 15th. Finally, Barclays restated an "equal weight" rating and set a $125.00 target price on shares of Agilent Technologies in a report on Friday, August 29th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $140.08.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.